Cargando…

Cetrotide administration in the early luteal phase in patients at high risk of ovarian hyperstimulation syndrome: A controlled clinical study

The aim of the present pilot study was to assess the feasibility and efficacy of Cetrotide administration in the early luteal phase in patients at high risk of ovarian hyperstimulation syndrome (OHSS), undergoing embryo cryopreservation following superovulation. A total of 135 patients at high risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, YA-QIN, YU, NAN, XU, WANG-MIN, XIE, QIN-ZHEN, YAN, WEN-JIE, WU, GENG-XIANG, YANG, JING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217764/ https://www.ncbi.nlm.nih.gov/pubmed/25371744 http://dx.doi.org/10.3892/etm.2014.2005

Ejemplares similares

Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?
por: Wang, Ya-Qin, et al.
Publicado: (2015)

Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study
por: Salama, Khalid M., et al.
Publicado: (2017)

Luteal phase ovarian stimulation for poor ovarian responders
por: Zhang, Wei, et al.
Publicado: (2018)

Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?
por: Gurbuz, Ali Sami, et al.
Publicado: (2016)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
por: Rubenfeld, Eryn Sara, et al.
Publicado: (2021)

Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study
por: Iliodromiti, Stamatina, et al.
Publicado: (2013)

Spontaneous ovarian hyperstimulation syndrome: Report of two cases
por: Gui, Juan, et al.
Publicado: (2019)

Luteal phase estradiol versus luteal phase GnRH antagonist administration: their effects on antral follicular size coordination and basal hormonal levels
por: Rashidi, Batool, et al.
Publicado: (2011)

Uterine adhesion: Is luteal phase prior to follicular phase in uterine adhesiolysis?
por: Fei, Yilin, et al.
Publicado: (2021)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Comparison of the effects of Duphaston and Cetrotide on oocyte and embryo quality in women undergoing ICSI: A cross-sectional study
por: Motaref, Niloofar, et al.
Publicado: (2020)

Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series
por: Lee, Dayong, et al.
Publicado: (2017)

Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?
por: Palomba, Stefano, et al.
Publicado: (2015)

Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study
por: Lainas, George T, et al.
Publicado: (2012)

Evaluation of pretreatment with Cetrotide in an antagonist protocol for patients with PCOS undergoing IVF/ICSI cycles: a randomized clinical trial
por: Eftekhar, Maryam, et al.
Publicado: (2018)

Effect of oral Utrogestan in comparison with Cetrotide on preventing luteinizing hormone surge in IVF cycles: A randomized controlled trial
por: Ghasemzadeh, Alieh, et al.
Publicado: (2020)

Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders?
por: Zhang, John
Publicado: (2015)

Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax
por: Ma, Xiaowei, et al.
Publicado: (2023)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Zika virus during controlled ovarian hyperstimulation
por: Joob, Beuy, et al.
Publicado: (2019)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Clinical Features of an Unrecognized 21-hydroxylase Deficiency Woman During Controlled Ovarian Hyperstimulation
por: Yang, Rui, et al.
Publicado: (2015)

Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
por: Olausson, Nina, et al.
Publicado: (2020)

Transcriptomes of bovine ovarian follicular and luteal cells
por: Romereim, Sarah M., et al.
Publicado: (2016)

Luteal Phase Ovarian Stimulation versus Follicular Phase Ovarian Stimulation results in different Human Cumulus cell genes expression: A pilot study
por: Chen, Yu-Chen, et al.
Publicado: (2021)

Luteal Phase in Assisted Reproductive Technology
por: Tesarik, Jan, et al.
Publicado: (2020)

Pregnancy Rate Following Luteal Phase Support in Iranian Women with Polycystic Ovarian Syndrome
por: Foroozanfard, Fatemeh, et al.
Publicado: (2014)

Luteal-phase protocol in poor ovarian response: a comparative study with an antagonist protocol
por: Wu, Yan, et al.
Publicado: (2017)

Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Ovarian, uterine, and luteal vascular perfusions during follicular and luteal phases in the adult cyclic female rabbits with special orientation to their histological detection of hormone receptor
por: Abdelnaby, Elshymaa A., et al.
Publicado: (2022)

Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism
por: Langroudi, Roghieh Molaei, et al.
Publicado: (2013)

The effect of controlled ovarian hyperstimulation on ovarian reserve via PTEN pathway
por: Sezginer, Perihan, et al.
Publicado: (2022)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_sbkgmcm9ov60ou9k66tln31uqs